59 results
8-K
AXLA
Axcella Health Inc.
29 Aug 23
Axcella Granted Patent for Long COVID Fatigue Treatment
8:17am
and complete its ongoing or planned clinical studies and clinical trials in a timely manner or at all due to patient or principal investigator recruitment
8-K
EX-99.1
AXLA
Axcella Health Inc.
29 Aug 23
Axcella Granted Patent for Long COVID Fatigue Treatment
8:17am
its ongoing or planned clinical studies and clinical trials in a timely manner or at all due to patient or principal investigator recruitment
8-K
EX-99.1
AXLA
Axcella Health Inc.
3 Aug 23
Axcella Reports Second Quarter Financial Results and Provides Business Update
8:04am
and complete its ongoing or planned clinical studies and clinical trials in a timely manner or at all due to patient or principal investigator recruitment
8-K
EX-99.1
AXLA
Axcella Health Inc.
4 May 23
Axcella Reports First Quarter Financial Results and Provides Business Update
4:33pm
studies and clinical trials in a timely manner or at all due to patient or principal investigator recruitment or availability challenges, clinical trial
8-K
EX-99.1
b5cf72wyc fff5
30 Mar 23
Axcella Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
8:22am
8-K
EX-99.1
0sry c0mp8fmf2mtls
15 Dec 22
Axcella Announces Program Reprioritization and Corporate Restructuring Move Positions Company to Best Focus on Long COVID Program
7:00am
8-K
EX-99.1
qn6yci0u
1 Nov 22
Axcella Reports Third Quarter Financial Results and Provides Business Update
8:02am
8-K
EX-99.1
6q6rqd qzl7f6
13 Oct 22
Entry into a Material Definitive Agreement
8:15am
424B5
fc0r4
13 Oct 22
Prospectus supplement for primary offering
7:55am
8-K
zimeqmj9vxc 6m3geiv
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-99.2
hq7vsi841veqzm5l6
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-99.1
2hexd0dma rknyjcw7ju
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
EX-99.1
xmf7qwzkp o6
12 Aug 22
Axcella Reports Second Quarter Financial Results and Provides Business Update
8:11am
8-K
wbcko3d6d
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.2
os07h22jh1l
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.1
pveg4c
2 Aug 22
Axcella Announces Highly Promising Results from Phase 2a Placebo Controlled Clinical Trial for Long COVID
4:06pm
8-K
EX-99.1
mc3vfj1 xk3r06
26 May 22
Axcella Announces Completion of Enrollment of Clinical Trial for Long COVID and Has Prioritized its Clinical Portfolio
8:12am